Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Active, Not Recruiting

Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients

NCT05153772

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Louisiana State University (LSU) Health Sciences Center - New Orleans Metairie, Louisiana, United States
  • Excel Diagnostics and Nuclear Oncology Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors

NCT04079712

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +20 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma

NCT04291885

Conditions
Adenocarcinoma, Carcinoma, Carcinoma Neuroendocrine Skin, +18 more
Locations
  • Port Macquarie Base Hospital Port Macquarie, New South Wales, Australia
  • Chris O'Brien Lifehouse Sydney, New South Wales, Australia
  • Melanoma Institute Australia Sydney, New South Wales, Australia
  • Royal North Shore Hospital Sydney, New South Wales, Australia
View all 20 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

NCT03049189

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Banner Health d.b.a. Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Stanford University Stanford, California, United States
  • Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
View all 52 locations
View Trial Details
Active, Not Recruiting

Targeted Therapy and Avelumab in Merkel Cell Carcinoma

NCT04261855

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • Mid North Coast Cancer Institute - Coffs Harbour Health Campus Coffs Harbour, New South Wales, Australia
  • Lake Macquarie Private Hospital Gateshead, New South Wales, Australia
  • Gosford Hospital Gosford, New South Wales, Australia
  • Wyong Hospital Hamlyn Terrace, New South Wales, Australia
View Trial Details

Related conditions